FERRARI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 9.757
EU - Europa 6.412
AS - Asia 3.749
SA - Sud America 472
Continente sconosciuto - Info sul continente non disponibili 96
AF - Africa 87
OC - Oceania 8
Totale 20.581
Nazione #
US - Stati Uniti d'America 9.614
IT - Italia 2.973
SG - Singapore 1.266
UA - Ucraina 980
CN - Cina 797
SE - Svezia 649
TR - Turchia 517
VN - Vietnam 510
BR - Brasile 396
HK - Hong Kong 380
DE - Germania 326
FI - Finlandia 308
IE - Irlanda 274
GB - Regno Unito 272
FR - Francia 257
RU - Federazione Russa 133
IN - India 80
CA - Canada 62
MX - Messico 61
JP - Giappone 52
BD - Bangladesh 42
PL - Polonia 35
AR - Argentina 32
NL - Olanda 31
BE - Belgio 30
ZA - Sudafrica 28
ES - Italia 24
CH - Svizzera 23
NG - Nigeria 21
CZ - Repubblica Ceca 19
AT - Austria 18
HU - Ungheria 12
IQ - Iraq 12
EU - Europa 10
UZ - Uzbekistan 10
EC - Ecuador 9
AE - Emirati Arabi Uniti 8
ID - Indonesia 8
JO - Giordania 8
KE - Kenya 8
PY - Paraguay 8
SM - San Marino 8
CL - Cile 7
CO - Colombia 7
LT - Lituania 7
PH - Filippine 7
AU - Australia 6
NP - Nepal 6
PK - Pakistan 6
DZ - Algeria 5
EG - Egitto 5
HN - Honduras 5
LB - Libano 5
MA - Marocco 5
MY - Malesia 5
PT - Portogallo 5
RO - Romania 5
SA - Arabia Saudita 5
TN - Tunisia 5
VE - Venezuela 5
AZ - Azerbaigian 4
BG - Bulgaria 4
AL - Albania 3
CR - Costa Rica 3
ET - Etiopia 3
GT - Guatemala 3
GY - Guiana 3
RS - Serbia 3
BO - Bolivia 2
DK - Danimarca 2
HR - Croazia 2
IL - Israele 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
LY - Libia 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SN - Senegal 2
TJ - Tagikistan 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GL - Groenlandia 1
GP - Guadalupe 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 20.486
Città #
Milan 1.790
San Jose 847
Chandler 826
Singapore 753
Jacksonville 737
Ashburn 723
Fairfield 586
Woodbridge 550
Ann Arbor 466
Hong Kong 377
Houston 349
Wilmington 292
Dublin 266
Dallas 258
Council Bluffs 257
Seattle 254
Princeton 252
Izmir 242
Nyköping 220
Dearborn 209
Beijing 206
Cambridge 201
The Dalles 186
Chicago 175
Como 173
Dong Ket 170
Rome 150
Boardman 149
Lauterbourg 125
Los Angeles 116
San Mateo 113
New York 109
Santa Clara 89
Ho Chi Minh City 69
Helsinki 68
Hanoi 67
London 54
Ogden 54
Tokyo 52
San Diego 50
Munich 46
Orem 44
Washington 44
Frankfurt am Main 41
Mexico City 41
São Paulo 38
Atlanta 30
Denver 30
Guangzhou 30
Düsseldorf 29
Warsaw 29
Phoenix 27
Ponte Lambro 27
Chennai 26
Montreal 26
Stockholm 24
Poplar 23
Brooklyn 22
Johannesburg 22
Brussels 21
Abuja 20
Buffalo 20
Des Moines 20
Shanghai 20
Varese 20
Berlin 18
Hefei 18
Kunming 18
Nanjing 18
Norwalk 18
Amsterdam 17
Manchester 16
Mountain View 16
Tianjin 16
San Francisco 15
Toronto 15
Boston 14
Brno 14
Da Nang 14
Hangzhou 14
Ankara 13
Pune 13
Columbus 12
Mumbai 12
Shenyang 12
Verona 12
Bologna 11
Jinan 11
Lugano 11
New Delhi 11
Redmond 11
Vienna 11
Belo Horizonte 10
Miami 10
Auburn Hills 9
Brasília 9
Haiphong 9
Redwood City 9
Rio de Janeiro 9
Shenzhen 9
Totale 13.805
Nome #
Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals 449
Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia 274
Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2 252
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study 236
Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. 228
7-hydroxymatairesinol potassium acetate (Hmr/LignanTM) from Norway spruce (Picea abies) knots and its active metabolite enterolactone exert estrogenic effects in the in MCF-7 cell model. 219
Muscarinic modulation of endogenous noradrenaline release from adrenergic terminals in the guinea-pig colon. 219
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study 218
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson’s patients 218
Association between the circadian course of endogenous noradrenaline and the hematopoietic cell cycle in mouse bone marrow. 214
Dopaminergic D-1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes 214
Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignantrade mark) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells. 212
Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection? 212
Dopaminergic inhibition of human neutrophils is exerted through D1-like receptors and affected by bacterial infection 210
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up 204
Are CYP1A2*1F and *1C associated with clozapine tolerability? A preliminary investigation 203
Twenty years of Lithium pharmacogenetics: A systematic review 203
cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms 202
Clopidogrel pharmacogenetics: Associations between genotype and stent thrombosis risk in patients with stent placement 200
Polymorphisms of dopamine receptor genes and risk of l-dopa–induced dyskinesia in parkinson’s disease 195
Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: Evidence for a D1-like receptor-dependent protective effect 194
Two patients with COMT inhibitor–induced hepatic dysfunction and UGT1A9 genetic polymorphism 193
Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients 190
Endogenous catecholamine synthesis, metabolism storage, and uptake in human peripheral blood mononuclear cells 188
Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils 188
Effect of chronic sympathetic denervation or chronic naltrexone treatment on the sensitivity of enteric cholinergic neurons to opioid receptor agonists. 182
HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines 181
Assessment of catecholamine content and metabolism in human pheripheral blood leukocytes subpopulation and leukemia cell lines 180
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR) 179
Simvastatin treatment in subjects at high cardiovascular risk modulates AT(1)R expression on circulating monocytes and T lymphocytes 175
Functional interaction between presynaptic receptors modulating transmitter release in the Autonomic Nervous System. 174
Treatment with simvastatin modifies AT1R expression and function in polymorphonuclear leukocyte of high cardiovascular risk subjects: a longitudinal study 173
Adverse reaction to COMT inhibitors in Parkinson's disease patients: possible association with the UGTIA9 gene haplotype 173
Ambulatory 24 hrs blood pressure minitoring in diabetic children and adolescent: a pilot study 172
Alla base della ridotta caduta pressoria notturna in giovani diabetici vi è un eccesso di dopamina? 170
Ultrastructural localization of tyrosine hydroxylase in human peripheral blood mononuclear cells: effect of stimulation with phytohaemagglutinin 170
Are adverse reactions to clozapina genetically predictable considering cytochrome P4501A2 haplotype? 167
Association of UDP-glucuronosyltransferase 1A9 polymorphisms with adverse reactions to catechol-o-methyltransferase inhibitors in Parkinson’s disease patients 167
Direct evidence for a functional relationschip betweene intracellular catecholamines and proliferation in human immune cells 165
Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines. A Longitudinal Study in Differentiated Thyroid Carcinoma during Short-Term Hypothyroidism and Thyroid Hormone Replacement. 165
Expression of apoptosis-related proteins and of mRNA for dopaminergic receptors in peripheral blood mononuclear cells from patients with Alzheimer disease. 164
Patients with type 2 diabetes vs. non-diabetic high-risk subjects: effect of simvastatin on angiotensin II type 1 receptor mRNA expression in leukocytes 161
Angiotensin II Reduces the Suppressive Function of Human CD4+CD25+ Regulatory T Lymphocytes. 161
Dopamine modulates cell death and survival in peripheral blood mononuclear cells: relevance for parkinson's disease. 160
Effect of interferon-beta on endogenous catecholamines in human peripheral blood mononuclear cells: interaction with interferon-gamma and relevance for activation-induced apoptosis 159
Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis 159
Clozapine-induced adverse effects in schizophrenic patients: Role of polymorphisms in P450 1 A2 gene 158
Evidence for a functional rilevance of glutamate receptors of the ampa type in the guinea pig colon 158
Interleukin-8 production induced by the endozepine triakontatetraneuropeptide in human neutrophils: role of calcium and pharmacological investigation of signal transduction pathways 158
Unravelling dopamine (and catecholamine) physiopharmacology in lymphocytes: open questions 158
Association between the circadian course of endogenuos noradrenaline and the hematopoietic cell cycle in the mouse bone marrow. , 157
Catecholamine content and production induced by differnt simuli in peripheral lynphocytes from patients with mutiple sclerosis 156
Is dopamine responsible for a reduction in nocturnal blood pressure fall in children with type 1 diabetes? 154
Foxp3 expressing CD4+ CD25+ and CD8+ CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 154
Sintesi intracellulare di catecolamine nei leucociti moninucleati umani: possibile ruolo nella sclerosi multipla. 151
Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review 151
6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients 149
Dopaminergic D1-like receptor activation reduces apoptosis in human peripheral blood mononuclear cells: possible relevance for Parkinson’s disease 149
Endogenuos catecholamine syntesis and metabolism in human leukocytes , Europen Journal of clinical investigation 149
Stimulation with phytohaemagglutinin induces the synthesis of catecholamines in human peripheral blood mononuclear cells: role of protein kinase C and contribution of intracellular calcium 149
Caratteristiche funzionali dei leucociti polimorfonucleati in pazienti dislipidemici: modificazione a 1 mese ed 1 anno di trattamento con simvastatina. 148
Evidence for a neuroimmunomodulatory and a hematopoietic role of the Luschka's coccygeal body 146
Terapia con statina in pazienti dislipidemici affetti da steatoepatite non alcolica: effetto su lipidi e funzione epatica. 146
Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects. 146
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance 145
Effect of quetiapine on inflammation and immunity: a systematic review 144
Evidence for a functional rilevance og glutamate receptor in the guibea-pig and human colon 143
Longitudinal evaluation of endogenous catecholamines and activation-induced apoptosis in lymphocytes from multiple sclerosis patients undergoing interferon-beta treatment 142
Expression of tyrosine hydroxylase and initiation of tyrosine hydroxylase gene transcription upon activation in human mononuclear leukocytes 142
Reactive oxygen species generation and AT1-receptors during prolonged simvastatin treatment in neutrophils by dyslipidemic subjects 141
Interazioni funzionali tra sistemi recettoriali diversi nella modulazione della liberazione di neurotrasmettitori nel plesso mienterico. 140
Evidence for a functional relationship between intracellular catecholamines and proliferation in human ummune cells 139
Espressione dell’mRNA per il recettore dell’angiotensina II di tipo 1 nei leucociti circolanti di soggetti ad alto rischio prima e dopo il trattamento con simvastatina. 138
Modulation of neurotransmitter release by opioid mu- and kappa-receptors from adrenergic terminals in the myenteric plexus of the guinea-pig colon: effect of alpha2-autoreceptor blockade. 138
Interferon beta reverts the effects of interferon gamma on endogenous catecholamines produced by blood mononuclear cells from multiple sclerosis patients 138
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. 138
Neurotransmitters, receptors and the neuroimmune network: a pharmacological approach to neuroimmunology 135
Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis 135
effect of simvastatin on angiotensin II type 1 receptor mRNA expression in leukocytes: a longitudinal study in dyslipidemic subjects. 131
Proteine kinase C regulates synthesis of catecholamine in human mononudclear leukocytes stimulated with phytohmagglutinin 130
Ruolo della protein chinasi C nella modulazione della produzione di catecolamine nei linfociti umani 129
Measurement of catecholamines in the mouse bone marrow by means of HPLC with electrochemical detection 128
Effect of interferon gamma and interferon beta on endogenous catecholamine production and tyrosine hydroxylase expression in human peripheral blood mononuclear cells: possible relevance for multiple sclerosis 127
Catecholamine production and tyrosine hydroxylase expression in lymphocytes of patients with multiple sclerosis 126
Catecolamine endogene nelle cellule mononucleate circolanti umane di pazienti con sclerosi multipla: possibile rilevanza dei processi apoptotici. 125
Dopamine-induced modulation of apoptosis in human peripheral blood monomuclear cells: evidence for a receptor-mediated antiapoptotic effect. 125
Modulazione dopaminergica dell’apoptosi in cellule mononucleate circolanti umane: possibile rilevanza per la malattia di Parkinson 124
Effect of chronic sympothetic denervation or chronic naltrexone treatment on the sensitivity of enteric cholinergic neurons to opioids receptor agonists. 123
Assessment of catecholamine content and metabolism in human peripheral blood leukocyte subpopulations and leukemia cell lines 122
Evidence for a functional relevance of glutamate receptors in the guinea-pig and human colon. 122
Ruolo della proteina chinasi C nella modulazione della produzione di catecolamine nei linfociti. 121
Catecholamine production and tyrosine hydroxylase expression in lymphocytes of patients with multiple sclerosis 121
Interferon-beta and interferon-gamma affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis. 121
Evidence for a functional relevance of glutamate receptors of the AMPA type in the guinea-pig colon 121
Polymorphisms of dopamine receptor genes and parkinson’s disease: Clinical relevance and future perspectives 121
Pharmacogenetics in antidyslipidemic treatment: a tool to predict CK elevation durin statin tretament?. 120
Endogenuos catecholamine metabolism in Human lynphocytes 119
Neurotransmitters, receptors and the neuroimmune network: a pharmacological approch to neuroimmunology. 119
Expression of the ANG II Type 1 Receptor on human CD4+CD25+hi regulatory T cells 119
Efetto degli inibitori della ricaptazione delle monoamine sulle catecolamine endogene nel linfociti umani 117
Totale 16.498
Categoria #
all - tutte 80.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.494 0 198 171 289 95 77 60 70 62 155 130 187
2022/20232.103 183 145 195 238 127 428 16 281 283 80 73 54
2023/20242.954 454 419 476 566 538 249 14 80 81 28 11 38
2024/20252.006 18 58 418 52 63 101 112 157 151 162 185 529
2025/20265.079 411 280 205 721 553 353 1.056 318 542 335 179 126
2026/2027433 212 221 0 0 0 0 0 0 0 0 0 0
Totale 20.581